Cleared Dual Track

K172604 - XW-100 Automated Hematology Analyzer for CLIA Waived Use

K172604 is an FDA 510(k) clearance for XW-100 Automated Hematology Analyzer fo..., manufactured by Sysmex America, Inc.. The device is a Class 2 Hematology device with product code GKZ cleared through the Dual Track 510(k) pathway after a 68-day FDA review.

K172604 · Sysmex America, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2017
Decision
68d
Days
Class 2
Risk

K172604 is an FDA 510(k) clearance for the XW-100 Automated Hematology Analyzer for CLIA Waived Use. Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Sysmex America, Inc. (Lincolnshire, US). The FDA issued a Cleared decision on November 6, 2017 after a review of 68 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Sysmex America, Inc. devices

FDA 510(k) Submission Details - K172604

510(k) Number K172604 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 30, 2017
Decision Date November 06, 2017
Days to Decision 68 days
Submission Type Dual Track
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
45d faster than avg
Panel avg: 113d · This submission: 68d
Pathway characteristics

GKZ Device Classification - Class 2, Special Controls

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 295
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K172604.
Athelas One
K181288 · Athelas, Inc. · Nov 2018
HemoScreen Hematology Analyzer
K180020 · Pixcell Medical Technologies, Ltd. · Oct 2018
cobas m 511 integrated hematology analyzer
K171655 · Roche Diagnostics Hematology, Inc. · Mar 2018
ABX MICROS ES 60 OT and ABX MICROS ES 60 CT
K170353 · HORIBA ABX SAS · Nov 2017
ADVIA 2120i, ADVIA 2120
K162977 · Siemens Healthcare Diagnostics · Aug 2017
Dextramer CMV Kit
K153538 · Immudex Aps · Mar 2017